Integrated Biopharma CFO Dina Masi's 2023 pay rises 10% to $330K
Integrated Biopharma reports 2023 executive compensation
By ExecPay News
Published: October 27, 2023
Integrated Biopharma reported fiscal year 2023 executive compensation information on October 27, 2023.
In 2023, four executives at Integrated Biopharma received on average a compensation package of $289K, a 1% increase compared to previous year.
Average pay of disclosed executives at Integrated Biopharma
Dina Masi, Chief Financial Officer, received $330K in total, which increased by 10% compared to 2022. 80% of Masi's compensation, or $264K, was in salary. Masi also received $7.1K in bonus, $48K in option awards, as well as $10K in other compensation.
Riva Sheppard, Chief Executive Officer, received a compensation package of $306K, which increased by 10% compared to previous year. 79% of the compensation package, or $242K, was in salary.
Christina Kay, Chief Executive Officer, earned $301K in 2023, a 9% increase compared to previous year.
E. Gerald Kay, Chairman, received $219K in 2023, which decreases by 24% compared to 2022.
Integrated Biopharma's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 27, 2023.